Top

Published in:

01-04-2010 | Original Paper

Prevalence of dementia disorders in the oldest-old: an autopsy study

Authors: Kurt A. Jellinger, Johannes Attems

Published in: Acta Neuropathologica | Issue 4/2010

Abstract

The prevalence of Alzheimer disease (AD) and vascular dementia (VD) increases with advancing age, but less so after age 90 years. A retrospective hospital-based study of the relative prevalence of different disorders was performed in 1,110 consecutive autopsy cases of demented elderly in Vienna, Austria (66% females, MMSE <20; mean age 83.3 ± 5.4 SD years). It assessed clinical, general autopsy data and neuropathology including immunohistochemistry. Neuropathologic diagnosis followed current consensus criteria. Four age groups (7–10th decade) were evaluated. In the total cohort AD pathology was seen in 82.9% (“pure” AD 42.9%; AD + other pathologies 39.9%), VD in 10.8% (mixed dementia, MIX, i.e. AD + vascular encephalopathy in 5.5%); other disorders in 5.7%, and negative pathology in 0.8%. The relative prevalence of AD increased from age 60 to 89 years and decreased slightly after age 90+, while “pure” VD diagnosed in the presence of vascular encephalopathy of different types with low neuritic AD pathology (Braak stages <3; mean 1.2–1.6) decreased progressively from age 60 to 90+; 85–95% of these patients had histories of diabetes, morphologic signs of hypertension, 65% myocardial infarction/cardiac decompensation, and 75% a history of stroke(s). Morphologic subtypes, subcortical arteriosclerotic (the most frequent), multi-infarct encephalopathy, and strategic infarct dementia showed no age-related differences. The relative prevalence of AD + Lewy pathology remained fairly constant with increasing age. Mixed dementia and AD with minor cerebrovascular lesions increased significantly with age, while other dementias decreased. This retrospective study using strict morphologic criteria confirmed increased prevalence of AD with age, but mild decline at age 90+, and progressive decline of VD, while AD + vascular pathologies including MIX showed considerable age-related increase, confirming that mixed pathologies account for most dementia cases in very old persons. A prospective clinicopathologic study in oldest-old subjects showed a significant increase in both AD and cerebral amyloid angiopathy (CAA), but decrease in VD over age 85, while in a small group of old subjects CAA without considerable AD pathology may be an independent risk factor for cognitive decline.

Aevarsson O, Skoog I (1996) A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc 44:1455–1460PubMed

Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Nakazawa H, Yamada T, Okada H, Yamamoto T, Kosaka K (2002) Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci 196:63–69PubMed

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Text Revision (DSM-IV-TR). American Psychiatric Association, Washington, DC

Andin U, Gustafson L, Passant U, Brun A (2005) A clinicopathological study of heart and brain lesions in vascular dementia. Dement Geriatr Cogn Disord 19:222–228PubMed

Ankri J, Poupard M (2003) Prevalence and incidence of dementia among the very old: review of the literature. Rev Epidemiol Sante Publique 51:349–360PubMed

Attems J, Jellinger KA, Lintner F (2005) Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222–231PubMed

Attems J, Quass M, Jellinger KA, Lintner F (2007) Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 257:49–55PubMed

Attems J, Lauda F, Jellinger KA (2008) Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol 255:70–76PubMed

Bacchetta JP, Kovari E, Merlo M, Canuto A, Herrmann FR, Bouras C, Gold G, Hof PR, Giannakopoulos P (2007) Validation of clinical criteria for possible vascular dementia in the oldest-old. Neurobiol Aging 28:579–585PubMed

10.

Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246:137–146PubMed

11.

Bancher C, Egensperger R, Kosel S, Jellinger K, Graeber MB (1997) Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 94:403–409PubMed

12.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer’s disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55:326–335PubMed

13.

Berlau DJ, Kahle-Wrobleski K, Head E, Goodus M, Kim R, Kawas C (2007) Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype. Arch Neurol 64:1193–1196PubMed

14.

Bermejo-Pareja F, Benito-Leon J, Vega S, Medrano MJ, Roman GC (2008) Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 264:63–72PubMed

15.

Borjesson-Hanson A, Edin E, Gislason T, Skoog I (2004) The prevalence of dementia in 95 year olds. Neurology 63:2436–2438PubMed

16.

Bowler JV (2005) Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 76(Suppl 5):v35–v44PubMed

17.

Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259

18.

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMed

19.

Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O’Sullivan A, Dening T, The Cambridge City Over-75 s Cohort Cc75c Study Neuropathology Collaboration (2009) Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge City over-75 s cohort (CC75C) study. J Alzheimers Dis 18:645–658PubMed

20.

Bufill E, Bartes A, Moral A, Casadevall T, Codinachs M, Zapater E, Rovira JC, Perez R, Roura P, Blesa R (2009) Prevalence of cognitive deterioration in people over 80-years-old: COGMANLLEU study. Neurologia 24:102–107PubMed

21.

Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59:768–773PubMed

22.

Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV (2006) Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 60:677–687PubMed

23.

Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease (1997) Neurobiol Aging 18:S1–S2

24.

Corrada MM, Brookmeyer R, Berlau D, Paganini-Hill A, Kawas CH (2008) Prevalence of dementia after age 90: results from the 90+ study. Neurology 71:337–343PubMed

25.

Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB (2000) The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol 57:713–719PubMed

26.

Crystal HA, Dickson D (2002) Cerebral infarcts in patients with autopsy proven Alzheimer’s disease (abstr.). Neurobiol Aging 23:207

27.

del Ser T, Hachinski V, Merskey H, Munoz DG (2005) Alzheimer’s disease with and without cerebral infarcts. J Neurol Sci 231:3–11PubMed

28.

Delaere P, He Y, Fayet G, Duyckaerts C, Hauw JJ (1993) Β A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol Aging 14:191–194PubMed

29.

Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36PubMed

30.

Ebly EM, Parhad IM, Hogan DB, Fung TS (1994) Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 44:1593–1600PubMed

31.

Esiri MM, Hyman BT, Beyreuther K, Masters CL (1997) Vascular dementia. In: Lantos P (ed) Greenfield’s neuropathology, 6th edn. Arnold Publishing, London, pp 204–210

32.

Esiri MM, Wilcock GK, Morris JH (1997) Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63:749–753PubMed

33.

Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet 354:919–920PubMed

34.

Fernando MS, Ince PG (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226:13–17PubMed

35.

Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117PubMed

36.

Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C (2004) Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 52:195–204PubMed

37.

Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W (2005) Survival following dementia onset: Alzheimer’s disease and vascular dementia. J Neurol Sci 229–230:43–49PubMed

38.

Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMed

39.

Fratiglioni L, De Ronchi D, Aguero-Torres H (1999) Worldwide prevalence and incidence of dementia. Drugs Aging 15:365–375PubMed

40.

Garcia JH, Brown GG (1992) Vascular dementia: neuropathologic alterations and metabolic brain changes. J Neurol Sci 109:121–131PubMed

41.

Giannakopoulos P, Hof PR, Surini M, Michel JP, Bouras C (1993) Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol 85:602–610PubMed

42.

Giannakopoulos P, Hof PR, Vallet PG, Giannakopoulos AS, Charnay Y, Bouras C (1995) Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians. Prog Neuropsychopharmacol Biol Psychiatry 19:577–592PubMed

43.

Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kovari E (2007) Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 130:2830–2836PubMed

44.

Graves AB, Larson EB, Edland SD, Bowen JD, McCormick WC, McCurry SM, Rice MM, Wenzlow A, Uomoto JM (1996) Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am J Epidemiol 144:760–771PubMed

45.

Greenberg SM, Gurol ME, Rosand J, Smith EE (2004) Amyloid angiopathy-related vascular cognitive impairment. Stroke 35:2616–2619PubMed

46.

Grinberg LT, Ferretti RE, Leite REP, Farfel JM, Santos EB, Andrade MP, Alho ATL, do Canno Lima M, Oliveira KC, Caetano-Junior A, SE T, Polichiso L, Zoriki CS, Pasqualucci CAG, Jacob-Filho W, Nitrini R, BABS Group (2009) Vascular dementia, an avoidable disease, may be much more common than presumed: a postmortem study in a large population-based series (abs.). Alzheimers Dement 5(suppl.1):P164

47.

Hall CB, Verghese J, Sliwinski M, Chen Z, Katz M, Derby C, Lipton RB (2005) Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study. Neurology 65:882–886PubMed

48.

Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 52:648–654PubMed

49.

Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, Libow LS, Lesser GT, Maroukian M, Grossman HT (2008) Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 65:1211–1217PubMed

50.

Head E, Corrada MM, Kahle-Wrobleski K, Kim RC, Sarsoza F, Goodus M, Kawas CH (2009) Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol Aging 30:1125–1134PubMed

51.

Hermann DM, Siccoli M, Brugger P, Wachter K, Mathis J, Achermann P, Bassetti CL (2008) Evolution of neurological, neuropsychological and sleep–wake disturbances after paramedian thalamic stroke. Stroke 39:62–68PubMed

52.

Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM (1998) Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168–1174PubMed

53.

Ikeda K, Akiyama H, Arai T, Sahara N, Mori H, Usami M, Sakata M, Mizutani T, Wakabayashi K, Takahashi H (1997) A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele. Ann Neurol 41:693–695PubMed

54.

Imhof A, Kovari E, von Gunten A, Gold G, Rivara CB, Herrmann FR, Hof PR, Bouras C, Giannakopoulos P (2007) Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci 257:72–79PubMed

55.

Jellinger KA, Bancher C (1998) Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 8:367–376PubMedCrossRef

56.

Jellinger KA (2001) Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. Arch Neurol 58:520–521PubMed

57.

Jellinger KA (2003) Plaque-predominant and tangle-predominant variants of Alzheimer’s disease. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 66–68

58.

Jellinger KA (2005) Understanding the pathology of vascular cognitive impairment. J Neurol Sci 229–230:57–63PubMed

59.

Jellinger KA, Attems J (2005) Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer’s disease. J Neurol Sci 229–230:37–41PubMed

60.

Jellinger KA (2006) Clinicopathological analysis of dementia disorders in the elderly: an update. J Alzheimers Dis 9:61–70PubMed

61.

Jellinger KA, Attems J (2006) Prevalence and impact of cerebrovascular pathology in Alzheimer’s disease and parkinsonism. Acta Neurol Scand 114:38–46PubMed

62.

Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113:349–388PubMed

63.

Jellinger KA, Attems J (2007) Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol 113:107–117PubMed

64.

Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257:80–87PubMed

65.

Jellinger KA (2008) The pathology of “vascular dementia”: a critical update. J Alzheimers Dis 14:107–123PubMed

66.

Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427–436PubMed

67.

Jellinger KA (2009) Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? Acta Neuropathol 117:101–110PubMed

68.

Jellinger KA, Attems J (2010) Tangel dominant dementia. In: Figueredo B, Meléndez F (eds) Neuroscience research advances. Nova Science Publishers Hauppauge, New York

69.

Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T (2004) Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 226:75–80PubMed

70.

Kase CS (1991) Epidemiology of multi-infarct dementia. Alzheimer Dis Assoc Disord 5:71–76PubMed

71.

Kawas CH, Corrada MM (2006) Alzheimer’s and dementia in the oldest-old: a century of challenges. Curr Alzheimer Res 3:411–419PubMed

72.

Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, Wharton SB, Weller RO, Brayne C (2009) Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 9:3PubMed

73.

Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, Greenberg SM (2009) Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72:1230–1235PubMed

74.

Kliegel M, Moor C, Rott C (2004) Cognitive status and development in the oldest old: a longitudinal analysis from the Heidelberg Centenarian Study. Arch Gerontol Geriatr 39:143–156PubMed

75.

Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E (2002) Incidence of vascular dementia in Rochester, Minn, 1985–1989. Arch Neurol 59:1605–1610PubMed

76.

Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, Edland SD, Rocca WA (2003) Vascular dementia in a population-based autopsy study. Arch Neurol 60:569–575PubMed

77.

Kobayashi M, Sato T, Sato A, Imamura T (2009) Oldest-old dementia in a Japanese memory clinic. Brain Nerve 61:972–978PubMed

78.

Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C (2005) Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 64:1548–1552PubMed

79.

Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ (2000) Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 57:1474–1479PubMed

80.

Leys D, Pasquier F, Parnetti L (1998) Epidemiology of vascular dementia. Haemostasis 28:134–150PubMed

81.

Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A (2000) Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. neurologic diseases in the elderly research group. Neurology 54:S4–S9PubMed

82.

Lopez Mongil R, Lopez Trigo JA, Castrodeza Sanz FJ, Tamames Gomez S, Leon Colombo T (2009) Prevalence of dementia in institutionalized patients: the RESYDEM study. Rev Esp Geriatr Gerontol 44:5–11PubMed

83.

Masuda J, Tanaka K, Ueda K, Omae T (1988) Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 19:205–210PubMed

84.

Mayeux R (2008) Alzheimer’s disease: epidemiology. In: Duyckaerts C, Litvan I (eds) Handbook of clinical neurology, vol 89, 3rd edn. Elsevier, Edinburgh, pp 195–205

85.

McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMed

86.

Miklossy J (2003) Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer’s disease. Neurol Res 25:605–610PubMed

87.

Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed

88.

Mizutani T, Shimada H (1992) Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 108:168–177PubMed

89.

Molano J, Boeve B, Ferman T, Smith G, Parisi J, Dickson D, Knopman D, Graff-Radford N, Geda Y, Lucas J, Kantarci K, Shiung M, Jack C, Silber M, Pankratz VS, Petersen R (2010) Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study. Brain 133:540–556PubMed

90.

Mura T, Dartigues J-F, Berr C (2010) How many dementia cases in France and Europe? Alternative projections and scenarios 2010–2050. Eur J Neurol 17:252–259PubMed

91.

Perls T (2004) Centenarians who avoid dementia. Trends Neurosci 27:633–636PubMed

92.

Perls T (2004) Dementia-free centenarians. Exp Gerontol 39:1587–1593PubMed

93.

Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesberry W, Davis DG, Nelson J, Hardman J, Masaki KH, Vogt MR, Launer LJ, White LR (2005) AD lesions and infarcts in demented and no-demented Japanese-American men. Ann Neurol 57:98–103PubMed

94.

Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629–1634PubMed

95.

Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29:125–132PubMed

96.

Polvikoski T, Sulkava R, Myllykangas L, Notkola IL, Niinisto L, Verkkoniemi A, Kainulainen K, Kontula K, Perez-Tur J, Hardy J, Haltia M (2001) Prevalence of Alzheimer’s disease in very elderly people: a prospective neuropathological study. Neurology 56:1690–1696PubMed

97.

Polvikoski T, Sulkava R, Rastas S, Sutela A, Niinisto L, Notkola IL, Verkkoniemi A, Viramo P, Juva K, Haltia M (2006) Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study. Neuroepidemiology 26:76–82PubMed

98.

Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R (2003) Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74:720–724PubMed

99.

Riekse RG, Leverenz JB, McCormick W, Bowen JD, Teri L, Nochlin D, Simpson K, Eugenio C, Larson EB, Tsuang D (2004) Effect of vascular lesions on cognition in Alzheimer’s disease: a community-based study. J Am Geriatr Soc 52:1442–1448PubMed

100.

Riley KP, Snowdon DA, Markesbery WR (2002) Alzheimer’s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51:567–577PubMed

101.

Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR, Dartigues JF, Engedal K, Hagnell O, Heeren TJ et al (1991) The prevalence of vascular dementia in Europe: facts and fragments from 1980 to 1990 studies: EURODEM Prevalence Research Group. Ann Neurol 30:817–824PubMed

102.

Rockwood K, Ebly E, Hachinski V, Hogan D (1997) Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 54:33–39PubMed

103.

Sachdev PS, Chen X, Joscelyne A, Wen W, Altendorf A, Brodaty H (2007) Hippocampal size and dementia in stroke patients: the Sydney stroke study. J Neurol Sci 260:71–77PubMed

104.

Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C (2009) Age, neuropathology, and dementia. N Engl J Med 360:2302–2309PubMed

105.

Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197–2204PubMed

106.

Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA (2009) The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 18:691–701PubMed

107.

Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66:200–208PubMed

108.

Schoos BJ, Hansen LA, Alford MF, Tiraboschi P, Ho GJ, Thal LJ, Corey-Bloom J (1999) So much dementia, so little pathology: AD in the oldest old (abs.). Neurology 52:A479

109.

Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T (1999) A neuropathological study of dementia in nursing homes over a 17-year period, in Shimane Prefecture, Japan. Gerontology 45:44–48PubMed

110.

Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT (2002) Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med 64:493–501PubMed

111.

Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A (1993) A population-based study of dementia in 85-year-olds. N Engl J Med 328:153–158PubMed

112.

Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62:406–413PubMed

113.

Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, Vinters HV (2010) Cerebral microinfarcts associated with severe cerebral β-amyloid angiopathy. Brain Pathol 20:459–467PubMed

114.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S (2005) Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. Neuropathol Appl Neurobiol 31:589–599PubMed

115.

Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, Kiuru-Enari S, Paetau A, Tienari PJ, Myllykangas L (2008) Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in α2-macroglobulin and tau: a population-based autopsy study. Ann Med 40:232–239PubMed

116.

Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287–1301PubMed

117.

Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115:599–609PubMed

118.

Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N (2009) Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 30:1936–1948PubMed

119.

The-Canadian-Study, Group oHaAW (2000) The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. Neurology 55:66–73

120.

Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Alzheimer disease without neocortical neurofibrillary tangles: “a second look”. Neurology 62:1141–1147PubMed

121.

Tolnay M, Villoz N, Probst A, Miserez AR (2003) Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer’s disease. Neuropathol Appl Neurobiol 29:80–84PubMed

122.

von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L (1999) Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 56:587–592

123.

White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, Hardman J, Davis D, Nelson J, Markesbery W (2005) Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol 18:224–227PubMed

124.

White L (2009) Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia Aging Study. J Alzheimers Dis 18:713–725PubMed

125.

Woodward M, Mackenzie IR, Feldman H (2006) High prevalence of multiple brain pathologies in dementia. Alzheimer’s Dement 2(Suppl1):S426

126.

Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C, Mukaetova-Ladinska E, McGee MA, O’Sullivan A, O’Connor D, Paykel ES, Huppert FA (2000) Neuropathological findings in the very old: results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci 903:490–496PubMed

127.

Yamada M, Tsukagoshi H, Otomo E, Hayakawa M (1987) Cerebral amyloid angiopathy in the aged. J Neurol 234:371–376PubMed

128.

Zaccai J, Ince P, Brayne C (2006) Population-based neuropathological studies of dementia: design, methods and areas of investigation: a systematic review. BMC Neurol 6:2. doi:10.1186/1471-2377-1186-1182 PubMed

129.

Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw JJ (2002) Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 103:481–487

130.

Zekry D, Duyckaerts C, Belmin J, Geoffre C, Moulias R, Hauw JJ (2003) Microvascular changes induced by cerebral amyloid angiopathy in the elderly: relationship with dementia. Acta Neuropathol 106:367–373PubMed

131.

Zekry D, Herrmann FR, Grandjean R, Meynet MP, Michel JP, Gold G, Krause KH (2008) Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status. Age Ageing 37:83–89PubMed

132.

Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ, Zhou B, Wu CB, Tang MN, Hong X, Li H (2005) Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 62:447–453PubMed

133.

Zhang ZX, Zahner GE, Roman GC, Liu XH, Wu CB, Hong Z, Hong X, Tang MN, Zhou B, Qu QM, Zhang XJ, Li H (2006) Socio-demographic variation of dementia subtypes in china: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian. Neuroepidemiology 27:177–187PubMed

Title: Prevalence of dementia disorders in the oldest-old: an autopsy study
Authors: Kurt A. Jellinger
Johannes Attems
Publication date: 01-04-2010
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 4/2010
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-010-0654-5

At a glance: The STEP trials

Springer Medicine

Prevalence of dementia disorders in the oldest-old: an autopsy study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Brain damage in a large cohort of solvent abusers

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2

Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis

The carboxy-terminal fragment of α1A calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics